AzurRx BioPharma

-$0.0338 (-3.81%) Today
+$0.0078 (+0.92%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell AZRX and other stocks, options, and ETFs commission-free!

About AZRX

AzurRx BioPharma, Inc. engages in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. Its product programs include MS1819, FW-1022: COVID-19 GI infections, and FW-420: Immune Checkpoint Inhibitor Colitis.

CEO
James E. Sapirstein
Employees
12
Headquarters
Delray Beach, Florida
Founded
2014

AZRX Key Statistics

Market Cap
67.57M
Price-Earnings Ratio
Dividend Yield
Average Volume
880.85K
High Today
$0.90
Low Today
$0.8522
Open Price
$0.88
Volume
720.94K
52 Week High
$2.63
52 Week Low
$0.6501

AZRX Earnings

-$0.46
-$0.31
-$0.15
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
per share
Actual
Expected Aug 13
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure